Treatment for multi-drug resistant tuberculosis (MDR-TB) in Uganda

dc.contributor.authorOmona, Kizito
dc.date.accessioned2024-04-02T09:39:41Z
dc.date.available2024-04-02T09:39:41Z
dc.date.issued2024-01
dc.description.abstractTuberculosis (TB) disease is a disease in humans caused by mycobacteria tuberculosis complex which comprises eight distinct but closely related organisms – M. bovis, M. caprae, M. africanum, M. microti, M. pinnipedii, M. mungi, M. orygis and M. canetti1. The most common and important agent of human disease is M. tuberculosis. The disease is spread from person to person through air. It affects the lungs and other parts of the body such as the brain, kidneys or spine. TB is treatable and curable. However, if not properly treated, persons with TB can die or suffer co-morbid conditions that grossly impair their economic productivity. The bacteria that causes TB can become more resistant to treatment when not properly managed, leading to drugresistant TB (DR-TB). Resistance leads to; (1) Multidrugresistant TB (MDR-TB) or (2) extensively drug resistant TB (XDR-TB). MDR-TB is caused by TB bacteria that are resistant to at least isoniazid and rifampin, which are the two most potent TB drugs while extensively drug resistant TB (XDR-TB) is a rare type of MDR-TB that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of the three injectable second-line drugs (amikacin, kanamycin, or capreomycin)2,3.en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12280/3080
dc.language.isoenen_US
dc.publisherAfrica Health Journalsen_US
dc.relation.ispartofseriesAfrica Health Journals;46(1); 27-30
dc.subjectMulti-drug resistant tuberculosisen_US
dc.subjectDrug-resistanten_US
dc.subjectRifampicin-resistant TBen_US
dc.subjectMDR/RR-TBen_US
dc.subject.Drug susceptibility testing (DST)en_US
dc.subjectPulmonary TB diseaseen_US
dc.titleTreatment for multi-drug resistant tuberculosis (MDR-TB) in Ugandaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Omona-Article-Health-2024-TreatmentMulti-Drug.pdf
Size:
532.74 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.85 KB
Format:
Item-specific license agreed upon to submission
Description: